Epidemiology of acute heart failure;Epidemiología de la insuficiencia cardíaca aguda

Medicina Clinica

Volumn 142, Issue SUPPL. 1, 2014, Pages 3-8

  Montes Santiago, Julio ^a   Arévalo Lorido, José Carlos ^b   Cerqueiro González, José Manuel ^c  

^a Servicio de Medicina Interna   (Spain)

^b Hospital de Zafra   (Spain)

^c HOSPITAL UNIVERSITARIO LUCUS AUGUSTI   (Spain)

Author keywords

Epidemiology; Heart failure; Hospitalizations; Mortality

Indexed keywords

ACUTE HEART FAILURE; ARTICLE; COMORBIDITY; DEVELOPED COUNTRY; HEALTH CARE; HOSPITAL ADMISSION; HOSPITAL READMISSION; MORBIDITY; MORTALITY; PREVENTIVE HEALTH SERVICE; SPAIN; TREATMENT PLANNING; ACUTE DISEASE; AGE DISTRIBUTION; AGED; COST OF ILLNESS; ECONOMICS; EPIDEMIOLOGY; FORECASTING; HEALTH; HEART FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; MIDDLE AGED; PREVALENCE; PROGNOSIS; STATISTICS AND NUMERICAL DATA; SURVIVAL; VERY ELDERLY;

ACUTE DISEASE; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COMORBIDITY; COST OF ILLNESS; FORECASTING; GLOBAL HEALTH; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INCIDENCE; MIDDLE AGED; PATIENT READMISSION; PREVALENCE; PROGNOSIS; SPAIN; SURVIVAL ANALYSIS;

EID: 84902966408     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/S0025-7753(14)70075-2     Document Type: Article

References (55)

1. Sayago-Silva I, García-López F, Segovia-Cubero J. Epidemiología de la insuficiencia cardiaca en Espan∼a en los ltimos 20 an∼os. Rev Esp Cardiol. 2013;66:649-56.
2. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics. 2013 Update. A report from the American Heart Association. Circulation. 2013;127:e6-245.
3. Montes-Santiago J. El riesgo cardiovascular en el arte. Madrid: S&H Medical Science Service; 2010.
4. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292:344-50.
5. McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al; ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803-69.
6. Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC Jr, et al. Prevalence and prognostic significance of heart failure stages. Application of the American College of Cardiology/American Heart Association Heart Failure staging criteria in the community. Circulation. 2007;115:1563-70.
7. Chen J, Normand SLT, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA. 2011;306:1669-78.
8. Gheorghiade M, Braunwald E. Hospitalizations for heart failure in the United States-a sign of hope. JAMA. 2011;306:1705-6.
9. Ross JS, Chen J, Lin Z, Bueno H, Curtis JP, Keenan PS, et al. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail. 2010;3: 97-103.
10. Setoguchi S, Stevenson LW. Hospitalizations in patients with heart failure: Who and why. J Am Coll Cardiol. 2009;54:1703-5.
11. Roger VL. The heart failure epidemic. Int J Environ Res Public Health. 2010;7: 1807-30.
12. Bradley HE, Curry L, Horwitz LI, Sipsma H, Wang Y, Walsh MN, et al. Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013;6:444-50.
13. Stiles S. CMS Penalties for excess HF readmissions: Quality incentive or Gigantic distraction? [consultado 21-10-2013]. Disponible en: www.medscape.com/viewarticle/812857-print
14. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e6-245.
15. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al; EuroHeart Survey Investigators. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27:2725-36.
16. Conde Martel A. Extrapolación de los resultados de los ensayos clínicos en insuficiencia cardíaca a los pacientes hospitalizados en medicina interna. Med Clin (Barc). 2013. [Epub ahead of print]. Disponible en: http://dx.doi.org/10.1016/j. medcli.2013.06.011
17. Dusemunda F, Steinerb M, Vuilliomenet A, Muller C, Bossart R, Regez K, et al. Multidisciplinary assessment to personalize length of stay in acute decompensated heart failure (OPTIMA II ADHF). J Clin Med Res. 2012;4:402-9.
18. Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, et al; Heart Failure Association of the European Society of Cardiology (HFA). EURObservational Research Programme: regional differences and 1-year followup results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2013;15:808-17.
19. Montes Santiago J. Epidemiología de la insuficiencia cardíaca aguda. En: Montero Pérez Barquero M, Conthe Gutiérrez P, coordinadores. Insuficiencia cardíaca aguda. Recomendaciones, diagnóstico y terapéuticas. Madrid: Jarpyo; 2007. p. 9-23.
20. Banegas JR, Rodríguez-Artalejo F, Guallar-Castillón P. Situación epidemiológica de la insuficiencia cardíaca en Espan∼a. Rev Esp Cardiol. 2006;6 Supl C:4C-9C.
21. Montes-Santiago J. Insuficiencia cardíaca con fracción de eyección preservada. Rev Clin Esp. 2009; Supl 2:3-10.
22. Cortina A, Reguero J, Segovia E, Rodríguez Lambert JL, Cortina R, et al. Prevalence of heart failure in Spain (a region in the north of Spain). Am J Cardiol. 2001;87:1417-9.
23. Gómez-Soto FM, Andrey JL, García-Egido AA, Escobar MA, Romero SP, García- Arjona R, et al. Incidence and mortality of heart failure: A community-based study. Int J Cardiol. 2011;151:40-5.
24. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22:A6-13.
25. Anguita Sánchez M, Crespo Leiro MG, De Teresa Galván E, Jiménez Navarro M, Alonso-Pulpón L, Mun∼iz García J. Prevalencia de la insuficiencia cardiaca en la población general espan∼ola mayor de 45 an∼os. Estudio PRICE. Rev Esp Cardiol. 2008;61:1041-9.
26. Martín Sánchez FJ, Marino Genicio R, Rodríguez- Adrada E, et al. El manejo de la insuficiencia cardíaca aguda en los servicios de urgencias hospitalarios espan∼oles en función de la edad. Rev Esp Cardiol. 2013; doi:10.1016/j.recesp.2013.04.020. [Epub ahead of print].
27. Ministerio de Sanidad, Política Social e Igualdad. Instituto de Información Sanitaria. Registro de altas - CMBD [consultado 2-11-2013]. Disponible en: http://pestadistico.msc.es
28. Instituto Nacional de Estadística (INE). Defunciones segn la causa de muerte [consultado 2-11-2013]. Disponible en: http://www.ine.es/inebase/cgi/ axi.
29. Principales causas de muerte por comunidades autónomas de residencia (2011). Encuesta de Morbilidad Hospitalaria, 2011 [consultado 2-11-2013]. Disponible en: http://www.ine.es/jaxi/tabla
30. Génova-Maleras R, Fernández de Larrea-Baz N, Álvarez-Martín E, Morant-Ginestar C, Catalá-López F. Impacto de la asignación de la insuficiencia cardiaca como causa básica de defunción en el cálculo de la mortalidad prematura cardiovascular en Espan∼a. Rev Esp Cardiol. 2013; doi:10.1016/j.recesp.2013.06.013. [Epub ahead of print].
31. Jessup M, Brozena SC. Guidelines for the management of heart failure. Differences in guideline perspectives. Cardiol Clin. 2007;25:497-506.
32. Drye E, Normand S-LT, Wang Y, Ross JS, Schreiner GC, Han L, et al. Comparison of hospital risk-standardized mortality rates using in-hospital and 30-day models: implications for hospital profiling. Ann Intern Med. 2012;156:19-26.
33. Fida N, Pina IL. Trends in heart failure hospitalizations. Curr Heart Fail Rep. 2012;9:346-53.
34. Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, et al; Get With the Guidelines Scientific Advisory Committee and Investigators. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction. Prevalence, therapies, and outcomes. Circulation. 2012;126:65-75.
35. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Euro Heart Failure Survey Programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003, 24:442-63.
36. Comisión Redactora SEMI-IC; Grupo de Trabajo de IC. La insuficiencia cardíaca en los servicios de medicina interna (estudio SEMI-IC). Med Clin (Barc). 2002;118: 605-10.
37. Montes Santiago J. Epidemiología de la insuficiencia cardíaca: aproximación al paciente real en Galicia. Galicia Clin. 2012; 73 Supl 2:S5-S11.
38. Montes-Santiago J, Rey García G, Mediero Domínguez A. Economic burden of heart failure in Galicia (Northwest of Spain): The GALICEP-costes study. European Federation of Internal Medicine, 6th Congress. Lisbon; 2007, May 23-26. Abstract book, P-49-07
39. Martínez A, Villaverde FJ, Roncoszek L, García-Castrillo Riesgo L. Factores sociodemográficos en el uso de los servicios de urgencias por los pacientes con insuficiencia cardiaca crónica. Emergencias. 2003;15:88-92.
40. Martínez-Sellés M, Doughty RN, Poppe K, Whalley GA, Earle N, Tribouilloy C, et al; Meta-Analysis Global Group In Chronic Heart Failure (MAGGIC). Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail. 2012;14:473-9.
41. Montes-Santiago J, Álvarez J, Rey G, Mediero M, Corral E, Miguélez D, et al. Diferencias geográficas en la mortalidad por insuficiencia cardíaca en Espan∼a. Matizando la paradoja espan∼ola. Rev Clin Esp. 2010; 210 Supl:250.
42. Montes-Santiago J, Fernández C, Guijarro-Merino R, San Román-Terán C, Monreal M. Prevalence of noncardiac comorbidities in patients hospitalized for heart failure in Spain. Europ J Intern Med. 2009;20 Suppl 1:S277.
43. Montero Pérez-Barquero M, Conthe Gutiérrez P, Román Sánchez P, García Alegría J, Forteza-Rey J; Grupo de Trabajo de Insuficiencia Cardíaca de Sociedad Espan∼ola de Medicina Interna (estudio SEMI-IC). Comorbilidad de los pacientes ingresados por insuficiencia cardíaca en los servicios de medicina interna. Rev Clin Esp. 2010;210:149-58.
44. Casado J, Montero M, Formiga F, Camafort M, Sánchez C, Muela A, et al.; Grupo RICA. Función renal en pacientes con insuficiencia cardiaca. Valor pronóstico. Rev Clin Esp. 2012;212:119-26.
45. Fonarow GC. Improving quality of care and outcomes for heart failure. Role of Registries. Circ J. 2011;75:1783-90.
46. Otero-Ravin∼a F, Grigorian-Shamagian L, Fransi-Galiana L, Názara-Otero C, Fernández-Villaverde JM, Del Alamo-Alonso A, et al; GALICAP Study researchers. Morbidity and mortality among heart failure patients in Galicia, NW Spain: the GALICAP Study. Int J Cardiol. 2009;136:56-63.
47. López Castro J, Almazán Ortega R, Pérez de Juan Romero M, González Juanatey JR. Factores pronósticos de mortalidad de la insuficiencia cardíaca en una cohorte del noroeste de Espan∼a. Estudio EPICOUR. Rev Clin Esp. 2010;210:438-47.
48. Quirós López R, García Alegría J, Martín Escalante MD, Trujillo Santos J, Villena Ruiz MA, Perea Milla E. Factores pronósticos y supervivencia a largo plazo tras un diagnóstico inicial de insuficiencia cardiaca. Med Clin (Barc). 2012;138:602-8.
49. Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA. Long-term survival after heart failure. A contemporary population-based perspective. Arch Intern Med. 2007;167:490-96.
50. Jhund PS, MacIntyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, et al. Longterm trends in first hospitalization for heart failures and subsequent survival between 1986 and 2003: A population study of 5.1 million people. Circulation. 2009;119:515-23.
51. Verdecchia P, Angeli F, Cavallini C, Gattobigio R, Gentile G, Staessen JA, et al. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. Eur Heart J. 2009;30:679-88.
52. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
53. Forés-Mateo G, Grau M, OFlaherty M, Ramos R, Elosua R, Violan-Fors C, et al. Análisis de la disminución de la mortalidad por enfermedad coronaria en una población mediterránea: Espan∼a 1988-2005. Rev Esp Cardiol. 2011;64:988-96.
54. Fonarow GC, Albert NM, Curtis AB, Gheorghiade M, Liu Y, Mehra MR, et al. Incremental reduction in risk of death associated with use of Guidelinerecommended therapies in patients with heart failure: A nested case-control analysis of IMPROVE HF. J Am Heart Assoc. 2012;1:16-26.
55. Grau M, Elosua R, Cabrera de León A, Guembe MJ, Baena-Díez JM, Vega Alonso T, et al. Factores de riesgo cardiovascular en Espan∼a en la primera década del siglo XXI: análisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS. Rev Esp Cardiol. 2011;64:295-304.